Literature DB >> 9514069

p53 and angiogenesis in non-small-cell lung cancer.

A Giatromanolaki, M I Koukourakis.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9514069      PMCID: PMC2149961          DOI: 10.1038/bjc.1998.138

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  12 in total

1.  Prognostic value of angiogenesis in operable non-small cell lung cancer.

Authors:  A Giatromanolaki; M Koukourakis; K O'Byrne; S Fox; R Whitehouse; D C Talbot; A L Harris; K C Gatter
Journal:  J Pathol       Date:  1996-05       Impact factor: 7.996

2.  Non-small cell lung cancer: c-erbB-2 overexpression correlates with low angiogenesis and poor prognosis.

Authors:  A Giatromanolaki; M I Koukourakis; K O'Byrne; L Kaklamanis; C Dicoglou; E Trichia; R Whitehouse; A L Harris; K C Gatter
Journal:  Anticancer Res       Date:  1996 Nov-Dec       Impact factor: 2.480

3.  Studies on clinicopathological features of lung cancer patients with K-ras/p53 gene alterations: comparison between younger and older groups.

Authors:  T Kashii; Y Mizushima; C E Lima; H Noto; H Sato; H Saito; Y Kusajima; M Kitagawa; K Yamamoto; M Kobayashi
Journal:  Oncology       Date:  1995 May-Jun       Impact factor: 2.935

4.  Comparative analysis of p53 gene mutations and protein accumulation in human non-small-cell lung cancer.

Authors:  B Top; W J Mooi; S G Klaver; L Boerrigter; P Wisman; H R Elbers; S Visser; S Rodenhuis
Journal:  Int J Cancer       Date:  1995-04-21       Impact factor: 7.396

5.  Antibody for detecting p53 protein by immunohistochemistry in normal tissues.

Authors:  F Pezzella; K Micklem; H Turley; K Pulford; M Jones; S Kocialkowski; D Delia; A Aiello; R Bicknell; K Smith
Journal:  J Clin Pathol       Date:  1994-07       Impact factor: 3.411

6.  Expression of p53 oncoprotein in non-small-cell lung cancer: a favorable prognostic factor.

Authors:  J S Lee; A Yoon; S K Kalapurakal; J Y Ro; J J Lee; N Tu; W N Hittelman; W K Hong
Journal:  J Clin Oncol       Date:  1995-08       Impact factor: 44.544

7.  Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1.

Authors:  K M Dameron; O V Volpert; M A Tainsky; N Bouck
Journal:  Science       Date:  1994-09-09       Impact factor: 47.728

8.  Neoangiogenesis and p53 protein in lung cancer: their prognostic role and their relation with vascular endothelial growth factor (VEGF) expression.

Authors:  G Fontanini; S Vignati; M Lucchi; A Mussi; A Calcinai; L Boldrini; S Chiné; V Silvestri; C A Angeletti; F Basolo; G Bevilacqua
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

9.  Platelet-derived endothelial cell growth factor expression correlates with tumour angiogenesis and prognosis in non-small-cell lung cancer.

Authors:  M I Koukourakis; A Giatromanolaki; K J O'Byrne; M Comley; R M Whitehouse; D C Talbot; K C Gatter; A L Harris
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

10.  The relationship of p53 immunostaining to survival in carcinoma of the lung.

Authors:  R McLaren; I Kuzu; M Dunnill; A Harris; D Lane; K C Gatter
Journal:  Br J Cancer       Date:  1992-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.